We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib.
- Authors
Reichardt, P; Blay, J-Y; Gelderblom, H; Schlemmer, M; Demetri, G D; Bui-Nguyen, B; McArthur, G A; Yazji, S; Hsu, Y; Galetic, I; Rutkowski, P
- Abstract
This phase III open-label trial investigated the efficacy of nilotinib in patients with advanced gastrointestinal stromal tumors following prior imatinib and sunitinib failure.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Vol 23, Issue 7, p1680
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdr598